This family of five flew in business class on Singapore Airlines during the holiday season—for $0 in cash. They spent more ...
Apnimed Inc., a pharmaceutical company developing first-in-class oral drugs that address the root causes of obstructive sleep apnea (OSA) and other sleep-related breathing diseases, today announced ...